Successful treatment of allergic bronchopulmonary candidiasis with a recombinant anti-immunoglobulin E antibody.
Allergy Unit, Hospital de Fuenlabrada, Madrid, Spain. dgolano@yahoo.es
D
D
González de Olano
E
E
González-Mancebo
M
M
Gandolfo Cano
A
A
Meléndez Baltanás
V
V
Valeri-Busto
M A
MA
Maracionero
E
E
Prats
J R
JR
Donado Uña
D018926:Anti-Allergic Agents / Q000008:administration & dosage*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000276:immunology; D061067:Antibodies, Monoclonal, Humanized; D002177:Candidiasis / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D008172:Lung Diseases, Fungal / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D011994:Recombinant Proteins / Q000008:administration & dosage; D012129:Respiratory Function Tests
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D011994:Recombinant Proteins; D000069444:Omalizumab; D007073:Immunoglobulin E